X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (877) 877
Newspaper Article (194) 194
Publication (146) 146
Book Review (33) 33
Patent (24) 24
Book / eBook (8) 8
Dissertation (7) 7
Book Chapter (6) 6
Web Resource (5) 5
Conference Proceeding (4) 4
Magazine Article (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (469) 469
index medicus (341) 341
female (287) 287
male (265) 265
middle aged (218) 218
oncology (181) 181
aged (174) 174
adult (162) 162
risk factors (143) 143
research (99) 99
animals (98) 98
article (97) 97
risk (86) 86
case-control studies (82) 82
insulin (81) 81
cancer (77) 77
insulin-like growth factor i - metabolism (70) 70
health aspects (67) 67
prospective studies (67) 67
public, environmental & occupational health (65) 65
insulin-like growth factor binding protein 3 - blood (61) 61
mice (60) 60
breast cancer (55) 55
analysis (53) 53
obesity (51) 51
cohort studies (49) 49
igf-i (49) 49
aged, 80 and over (48) 48
growth-factor-i (48) 48
epidemiology (47) 47
factor-i (46) 46
prostate cancer (46) 46
abridged index medicus (43) 43
endocrinology & metabolism (41) 41
care and treatment (40) 40
cells (40) 40
expression (40) 40
metformin (40) 40
breast-cancer (38) 38
physiological aspects (37) 37
adolescent (36) 36
cell biology (36) 36
diabetes (36) 36
mortality (36) 36
treatment outcome (36) 36
body mass index (34) 34
follow-up studies (34) 34
genetic aspects (33) 33
neurosciences (33) 33
postmenopausal women (33) 33
surgery (33) 33
diagnosis (32) 32
cell line, tumor (31) 31
studies (31) 31
association (30) 30
insulin-like growth factor i - analysis (30) 30
men (30) 30
child (29) 29
insulin-like growth factors (29) 29
metabolism (29) 29
proteins (29) 29
research article (29) 29
biochemistry & molecular biology (28) 28
time factors (28) 28
women (28) 28
biomarkers, tumor - blood (27) 27
breast neoplasms - pathology (27) 27
medicine & public health (27) 27
body-mass index (26) 26
medicine (26) 26
multidisciplinary sciences (26) 26
prognosis (26) 26
glucose (25) 25
growth (25) 25
mutation (25) 25
orthopedics (25) 25
phosphorylation (25) 25
retrospective studies (25) 25
united states (25) 25
c-peptide (24) 24
incidence (24) 24
medicine, general & internal (24) 24
pregnancy (24) 24
clinical neurology (22) 22
clinical trials (22) 22
cross-sectional studies (22) 22
genetics (22) 22
genetics & heredity (22) 22
growth factors (22) 22
insulin - blood (22) 22
insulin resistance (22) 22
prevention (22) 22
biomarkers - blood (21) 21
disease progression (21) 21
health risk assessment (21) 21
hematology (21) 21
medical research (21) 21
metformin - pharmacology (21) 21
pediatrics (21) 21
prostate-cancer (21) 21
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Physics - Stacks (1) 1
Robarts - Stacks (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1026) 1026
French (137) 137
German (7) 7
Chinese (1) 1
Japanese (1) 1
Portuguese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 8, pp. 723 - 732
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article